Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

A man developed alopecia areata after starting cancer treatment with vandetanib.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Ciproterone acetate improves hair regrowth and acne in most female patients.